Literature DB >> 7842650

Analysis of thrombin generation in plasma.

H Kessels1, G Willems, H C Hemker.   

Abstract

Thrombin is the central enzyme of haemostasis. Information on the production and inhibition of thrombin in plasma is important for evaluating the state of the coagulation system. Measurement of thrombin generation in plasma using small oligopeptide chromogenic substrates gives rise to a signal that not only reflects the enzymatic activity of free thrombin, but also contains a contribution of the complex of thrombin with one of its inhibitors, alpha 2-macroglobulin. This paper describes a mathematical procedure to extract from the measured curves the signal due to free thrombin only. The time integral of this free thrombin curve, which we call the thrombin potential, is a parameter which condenses much of the information present in such a curve. Thrombin production from prothrombin can be calculated from the concentration of free thrombin, when the rate constants governing the decay of thrombin are known. It is described how this calculation can be performed, accounting for the consumption of some of the inhibitors of thrombin during coagulation. Measurement of the time integral of the thrombin concentration promises clinical applicability of thrombin generation tests. It is based on the continuous registration of conversion of chromogenic substrate by thrombin during coagulation in plasma. It is shown how the curves obtained by this test can be analysed by a procedure which is analogous to the analysis of curves measured by subsampling from clotting plasma.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7842650     DOI: 10.1016/0010-4825(94)90024-8

Source DB:  PubMed          Journal:  Comput Biol Med        ISSN: 0010-4825            Impact factor:   4.589


  6 in total

1.  Cellular regulation of blood coagulation: a model for venous stasis.

Authors:  James E Campbell; Kathleen E Brummel-Ziedins; Saulius Butenas; Kenneth G Mann
Journal:  Blood       Date:  2010-09-23       Impact factor: 22.113

2.  Direct Amplification of Tissue Factor:Factor VIIa Procoagulant Activity by Bile Acids Drives Intrahepatic Coagulation.

Authors:  Kevin S Baker; Anna K Kopec; Asmita Pant; Lauren G Poole; Holly Cline-Fedewa; Dora Ivkovich; Mojtaba Olyaee; Benjamin L Woolbright; Adam Miszta; Hartmut Jaeschke; Alisa S Wolberg; James P Luyendyk
Journal:  Arterioscler Thromb Vasc Biol       Date:  2019-08-15       Impact factor: 8.311

3.  In vitro and in vivo characterization of a reversible synthetic heparin analog.

Authors:  Matthew F Whelihan; Brian Cooley; Yongmei Xu; Rafal Pawlinski; Jian Liu; Nigel S Key
Journal:  Thromb Res       Date:  2015-12-10       Impact factor: 3.944

4.  VE-1902-A direct thrombin inhibitor with reversible covalent mechanism of action shows efficacy with reduced bleeding in rodent models of thrombosis.

Authors:  Mohanram Sivaraja; Daniel M Clemens; Sivan Sizikov; Subhadra Dash; Chengpei Xu; Matthew Rienzo; Bo Yang; Molly Ryan; Madhuri Chattopadhyay; Lev Igoudin; Stephanie S Chang; Samuel Keutzer; Piotr Zalicki; M Angels Estiarte; Timothy P Shiau; Kevin M Short; David C Williams; Anirban Datta; Nicola Pozzi; Enrico Di Cera; C Michael Gibson; Keith A A Fox; David B Kita
Journal:  Thromb Res       Date:  2020-04-19       Impact factor: 3.944

5.  The Impact of Age and BMI on the VWF/ADAMTS13 Axis and Simultaneous Thrombin and Plasmin Generation in Hospitalized COVID-19 Patients.

Authors:  Kiruphagaran Thangaraju; Upendra Katneni; Imo J Akpan; Kenichi Tanaka; Tiffany Thomas; Saini Setua; Julie A Reisz; Francesca Cendali; Fabia Gamboni; Travis Nemkov; Stacie Kahn; Alexander Z Wei; Jacob E Valk; Krystalyn E Hudson; David J Roh; Chiara Moriconi; James C Zimring; Angelo D'Alessandro; Steven L Spitalnik; Richard O Francis; Paul W Buehler
Journal:  Front Med (Lausanne)       Date:  2022-01-10

Review 6.  Thrombin-Fibrin(ogen) Interactions, Host Defense and Risk of Thrombosis.

Authors:  Anne-Marije Hulshof; H Coenraad Hemker; Henri M H Spronk; Yvonne M C Henskens; Hugo Ten Cate
Journal:  Int J Mol Sci       Date:  2021-03-04       Impact factor: 5.923

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.